Original Article

Relationship Between Serum 25-Hydroxy Vitamin D Level and Breast Cancer Prognostic Factors

Abstract

Vitamin D deficiency plays an important role in the development of various diseases, including cancer. Regarding the high prevalence of breast cancer and vitamin D deficiency in Iran, this study aimed to investigate the relationship between vitamin D deficiencies and prognostic factors in breast cancer. This descriptive-analytical cross-sectional study was performed from March 2015 to March 2017 at Imam Reza hospital in Kermanshah city, Iran. 145 breast cancer patients with pathologic confirmation and before the neoadjuvant or adjuvant treatments were included by simple and convenient sampling. Serum 25(OH) D levels were measured in all patients before receiving treatment. The collected data were analyzed by using SPSS software (version. 20), and the relationship between the levels of 25(OH) D and the studied factors was assessed by inferential statistical tests in each group. The results showed that there was a statistically significant direct relationship between serum vitamin D levels and some factors, including age, ER, and PR, but a significant inverse relationship was observed between serum vitamin D levels and the level of ki67 and metastasis. There was no statistically significant relationship between the mean serum level of vitamin D and tumor grade and P53 receptor, but high levels of vitamin D were associated with low-grade tumors and P53 negativity. According to the findings, lower levels of vitamin D can be associated with higher levels of ki67 and P53, higher-grade breast cancer, a higher rate of metastases, as well as lower percentage of hormone receptor positivity.

1. Heydarheydari S, Rezaeijo SM, Cheki M, Khodamoradi E, Khoshgard K. Diagnostic Efficacy of Technetium-99m-Sestamibi Scintimammography in Comparison with Mammography to Detect Breast Lesions: A Systematic Review. Arch Breast Cancer 2018;5:98-105.
2. Heydarheydari S, Haghparast A. Diagnostic Value of PET/CT in Comparison with Other Conventional Imaging Modalities for the Evaluation of Breast Cancer Recurrence: A Systematic Review of the Literature. Arch Breast Cancer 2016;3:77-82.
3. Sadeghi S. The relationship between anxiety and depression with breast cancer screening in women referring to the mammography clinics in Kermanshah, 2013-2014. J of Clin Res Paramed Sci 2015;4:231-7.
4. Holakouie Naieni K, Ardalan A, Mahmoodi M, Motevalian A, Yahyapoor Y, Yazdizadeh B. Risk factors of breast cancer in north of Iran: a case-control in Mazandaran Province. Asian Pac J Cancer Prev 2007;8:395-8.
5. Park Y, Brinton LA, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health–AARP Diet and Health Study. Am J Clin Nutr 2009;90:664-71.
6. Rezaeijo SM, Ghorvei M, Mofid B. Predicting breast cancer response to neoadjuvant chemotherapy using ensemble deep transfer learning based on CT images. J Xray Sci Technol 2021;29:835-50.
7. Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM, et al. Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res 2016;76:5423-30.
8. Uray IP, Brown PH. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed. Clin Cancer Prev 2010:147-62.
9. Atoum M, Alzoughool F. Vitamin D and breast cancer: latest evidence and future steps. Breast Cancer (Auckl) 2017;11:1178223417749816.
10. Colston K. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9:45-59.
11. Fidan E, Yildiz B, Ozdemir F, Ucar U, Kavgaci H, Orem A, et al. Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study. Asian Biomed 2011;5:663-7.
12. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-7.
13. Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre-and postmenopausal women. Am J Clin Nutr 2010;91:1699-707.
14. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2011;20:187-98.
15. McCullough ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ, et al. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2005;14:2898-904.
16. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH, et al. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 2011;18:1830-6.
17. Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women’s Health Study. Cancer Causes Control 2007;18:775-82.
18. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 2011;13:R74.
19. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2009;2:598-604.
20. Golmohammadi R, Pejhan A. Gene experison of cell proliferative marker Ki67 in breast cancer. J Gorgan Univ Med Sci 2011;13:65-71.
21. Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, et al. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer Sci 2010;101:1234-40.
22. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 2011;13:R50.
23. Kadivar M, Bozorgmehr N. Study of Cytologic Grading of Samples Obtained from Breast Carcinoma Cases Referred to Milad and Rasoul-e-Akram Hospitals between 2004 and 2005. Razi J Med Sci 2007;14:129-38.
Files
IssueVol 60 No 11 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/acta.v60i11.11656
Keywords
Vitamin D Breast cancer Prognostic factors
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Farshchian N, Rashidi M, Heydarheydari S, Farshchian N. Relationship Between Serum 25-Hydroxy Vitamin D Level and Breast Cancer Prognostic Factors. Acta Med Iran. 2023;60(11):707-713.